1.61
+0.0601(+3.88%)
Currency In USD
Previous Close | 1.55 |
Open | 1.57 |
Day High | 1.65 |
Day Low | 1.57 |
52-Week High | 3 |
52-Week Low | 1.1 |
Volume | 143,323 |
Average Volume | 182,859 |
Market Cap | 12.04M |
PE | -0.81 |
EPS | -2 |
Moving Average 50 Days | 1.66 |
Moving Average 200 Days | 1.63 |
Change | 0.07 |
If you invested $1000 in Intelligent Bio Solutions Inc. (INBS) since IPO date, it would be worth $0.61 as of September 08, 2025 at a share price of $1.62. Whereas If you bought $1000 worth of Intelligent Bio Solutions Inc. (INBS) shares 3 years ago, it would be worth $13.1 as of September 08, 2025 at a share price of $1.62.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Intelligent Bio Solutions Achieves Record Monthly Sales of 12,500+ Units of Higher-Margin Cartridges in July
GlobeNewswire Inc.
Aug 19, 2025 12:30 PM GMT
Company reports all-time-high monthly cartridge sales for July with 60% year-on-year growthNEW YORK, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering
Intelligent Bio Solutions to Participate in the Sidoti Micro-Cap Virtual Conference on August 20-21, 2025
GlobeNewswire Inc.
Aug 12, 2025 12:30 PM GMT
NEW YORK, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing and screening solutions, today announced that its
Intelligent Bio Solutions Announces Preliminary Fiscal Fourth Quarter Revenue with Double-Digit Sequential and Year-Over-Year Growth and Strong Operational Momentum
GlobeNewswire Inc.
Aug 07, 2025 12:30 PM GMT
Company anticipates fiscal fourth quarter sequential and year-on-year revenue growth of approximately 16% Company advanced efforts to secure U.S. FDA 510(k) clearance for planned U.S. market entry and strengthened global readiness through system upgr